🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate the safety, tolerability, an...
Status
Not Yet Recruiting
Location
Centre Universitaire Hospitalier Vaudois (CHUV)
Start Date
2026-01-01
Trial ID
NCT07377253
Treatments Being Tested
This will be a multi-center, randomized withdrawal, open-label, non-treatme...
Status
Completed
Location
Montreal Neurological Institute, McGill University
Start Date
2015-01
Trial ID
NCT02328482
Treatments Being Tested
This will be a double-blind, randomized, placebo-controlled, single ascendi...
Status
Completed
Location
PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital
Start Date
2016-03
Trial ID
NCT02725957
Treatments Being Tested
BB-OPMD-202 is a randomized, double-blind, placebo-controlled study of IV t...
Status
Withdrawn
Location
Ecogene-21
Start Date
2017-06-15
Trial ID
NCT04226924
Treatments Being Tested
A Phase 2 study investigating the addition of cRIT 131I-omburtamab to irino...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-04-04
Trial ID
NCT04743661
An open-label, proof-of-concept study to evaluate the safety and treatment ...
Status
Withdrawn
Location
Austin Health
Start Date
2023-03-03
Trial ID
NCT05332678
Treatments Being Tested